{"id":82,"date":"2023-12-21T13:49:47","date_gmt":"2023-12-21T05:49:47","guid":{"rendered":"http:\/\/localhost\/wordpress4\/?p=82"},"modified":"2024-07-15T16:03:34","modified_gmt":"2024-07-15T08:03:34","slug":"%e7%8b%82%e8%b3%80%ef%bc%81%e5%8d%94%e5%8a%a9%e7%97%85%e6%af%92%e8%bc%89%e9%ab%94%e5%9f%ba%e5%9b%a0%e6%b2%bb%e7%99%82%e6%87%89%e7%94%a8%e6%96%bc%e8%a6%96%e7%b6%b2%e8%86%9c%e7%97%85%e8%ae%8a%e7%96%be","status":"publish","type":"post","link":"https:\/\/www.vcro.com.tw\/?p=82","title":{"rendered":"Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA."},"content":{"rendered":"<figure class=\"wp-block-post-featured-image\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1024\" src=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d069ce71-e394-4363-baf4-aa99f5f7b942.jpg\" class=\"attachment-post-thumbnail size-post-thumbnail wp-post-image\" alt=\"\" style=\"object-fit:cover;\" srcset=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d069ce71-e394-4363-baf4-aa99f5f7b942.jpg 1024w, https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d069ce71-e394-4363-baf4-aa99f5f7b942-300x300.jpg 300w, https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d069ce71-e394-4363-baf4-aa99f5f7b942-150x150.jpg 150w, https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d069ce71-e394-4363-baf4-aa99f5f7b942-768x768.jpg 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n<p>In December 2023, the professional team from VCRO assisted the client in submitting the clinical trial application of their viral vector for the use of gene therapy in the treatment of\u00a0retinal diseases. The team successfully obtained US FDA approval to proceed with Phase I\/II clinical trials. We successfully supported our clients in smoothly advancing to the Phase I\/II clinical trial stage. VCRO is here to accompany you through every stage of the clinical trial process.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In December 2023, the professional team from VCRO assisted the client in submitting the clinical trial application of their viral vector for the use of gene therapy in the treatment of\u00a0retinal diseases. The team successfully obtained US FDA approval to proceed with Phase I\/II clinical trials. We successfully supported our clients in smoothly advancing to [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1727,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-82","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vcro-express"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\r\n<title>Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA. - VCRO<\/title>\r\n<meta name=\"description\" content=\"Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA. VCRO -\" \/>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/www.vcro.com.tw\/?p=82\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA. - VCRO\" \/>\r\n<meta property=\"og:description\" content=\"Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA. VCRO -\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/www.vcro.com.tw\/?p=82\" \/>\r\n<meta property=\"og:site_name\" content=\"VCRO\" \/>\r\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\" \/>\r\n<meta property=\"article:published_time\" content=\"2023-12-21T05:49:47+00:00\" \/>\r\n<meta property=\"article:modified_time\" content=\"2024-07-15T08:03:34+00:00\" \/>\r\n<meta property=\"og:image\" content=\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d069ce71-e394-4363-baf4-aa99f5f7b942.jpg\" \/>\r\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\r\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\r\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\r\n<meta name=\"author\" content=\"VCRO\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"VCRO\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=82#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=82\"},\"author\":{\"name\":\"VCRO\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\"},\"headline\":\"Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA.\",\"datePublished\":\"2023-12-21T05:49:47+00:00\",\"dateModified\":\"2024-07-15T08:03:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=82\"},\"wordCount\":102,\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=82#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d069ce71-e394-4363-baf4-aa99f5f7b942.jpg\",\"articleSection\":[\"VCRO express\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=82\",\"url\":\"https:\/\/www.vcro.com.tw\/?p=82\",\"name\":\"Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA. - VCRO\",\"isPartOf\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=82#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=82#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d069ce71-e394-4363-baf4-aa99f5f7b942.jpg\",\"datePublished\":\"2023-12-21T05:49:47+00:00\",\"dateModified\":\"2024-07-15T08:03:34+00:00\",\"description\":\"Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA. VCRO -\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vcro.com.tw\/?p=82#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vcro.com.tw\/?p=82\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=82#primaryimage\",\"url\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d069ce71-e394-4363-baf4-aa99f5f7b942.jpg\",\"contentUrl\":\"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d069ce71-e394-4363-baf4-aa99f5f7b942.jpg\",\"width\":1024,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vcro.com.tw\/?p=82#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.vcro.com.tw\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vcro.com.tw\/#website\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"name\":\"VCRO - Asia Pacific CRO Based in Taiwan\",\"description\":\"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan\",\"publisher\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\"},\"alternateName\":\"VCRO\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vcro.com.tw\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.vcro.com.tw\/#organization\",\"name\":\"Virginia Contract Research Organization Co., Ltd.\",\"alternateName\":\"VCRO\",\"url\":\"https:\/\/www.vcro.com.tw\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"contentUrl\":\"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png\",\"width\":512,\"height\":512,\"caption\":\"Virginia Contract Research Organization Co., Ltd.\"},\"image\":{\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/people\/\/100057388670681\/\",\"https:\/\/line.me\/R\/ti\/p\/277jsobo\",\"http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43\",\"name\":\"VCRO\",\"sameAs\":[\"https:\/\/www.vcro.com.tw\"],\"url\":\"https:\/\/www.vcro.com.tw\/?author=1\"}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA. - VCRO","description":"Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA. VCRO -","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vcro.com.tw\/?p=82","og_locale":"en_US","og_type":"article","og_title":"Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA. - VCRO","og_description":"Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA. VCRO -","og_url":"https:\/\/www.vcro.com.tw\/?p=82","og_site_name":"VCRO","article_publisher":"https:\/\/www.facebook.com\/people\/\/100057388670681\/","article_published_time":"2023-12-21T05:49:47+00:00","article_modified_time":"2024-07-15T08:03:34+00:00","og_image":[{"width":1024,"height":1024,"url":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d069ce71-e394-4363-baf4-aa99f5f7b942.jpg","type":"image\/jpeg"}],"author":"VCRO","twitter_card":"summary_large_image","twitter_misc":{"Written by":"VCRO"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.vcro.com.tw\/?p=82#article","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/?p=82"},"author":{"name":"VCRO","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43"},"headline":"Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA.","datePublished":"2023-12-21T05:49:47+00:00","dateModified":"2024-07-15T08:03:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.vcro.com.tw\/?p=82"},"wordCount":102,"publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"image":{"@id":"https:\/\/www.vcro.com.tw\/?p=82#primaryimage"},"thumbnailUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d069ce71-e394-4363-baf4-aa99f5f7b942.jpg","articleSection":["VCRO express"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.vcro.com.tw\/?p=82","url":"https:\/\/www.vcro.com.tw\/?p=82","name":"Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA. - VCRO","isPartOf":{"@id":"https:\/\/www.vcro.com.tw\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vcro.com.tw\/?p=82#primaryimage"},"image":{"@id":"https:\/\/www.vcro.com.tw\/?p=82#primaryimage"},"thumbnailUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d069ce71-e394-4363-baf4-aa99f5f7b942.jpg","datePublished":"2023-12-21T05:49:47+00:00","dateModified":"2024-07-15T08:03:34+00:00","description":"Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA. VCRO -","breadcrumb":{"@id":"https:\/\/www.vcro.com.tw\/?p=82#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vcro.com.tw\/?p=82"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vcro.com.tw\/?p=82#primaryimage","url":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d069ce71-e394-4363-baf4-aa99f5f7b942.jpg","contentUrl":"https:\/\/www.vcro.com.tw\/wp-content\/uploads\/2024\/07\/d069ce71-e394-4363-baf4-aa99f5f7b942.jpg","width":1024,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/www.vcro.com.tw\/?p=82#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vcro.com.tw\/"},{"@type":"ListItem","position":2,"name":"Great News! Approval for Phase I\/II clinical trials of virus vector gene therapy for retinal diseases has been successfully secured from the US FDA."}]},{"@type":"WebSite","@id":"https:\/\/www.vcro.com.tw\/#website","url":"https:\/\/www.vcro.com.tw\/","name":"VCRO - Asia Pacific CRO Based in Taiwan","description":"Virginia Contract Research Organization Co., Ltd.- Asia Pacific CRO Based in Taiwan","publisher":{"@id":"https:\/\/www.vcro.com.tw\/#organization"},"alternateName":"VCRO","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vcro.com.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.vcro.com.tw\/#organization","name":"Virginia Contract Research Organization Co., Ltd.","alternateName":"VCRO","url":"https:\/\/www.vcro.com.tw\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/","url":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","contentUrl":"https:\/\/vcro.com.cn\/wp-content\/uploads\/2024\/07\/VCRO-logo-512-512-background-transparent.png","width":512,"height":512,"caption":"Virginia Contract Research Organization Co., Ltd."},"image":{"@id":"https:\/\/www.vcro.com.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/people\/\/100057388670681\/","https:\/\/line.me\/R\/ti\/p\/277jsobo","http:\/\/weixin.qq.com\/r\/eRD64tPE0I6vrZeB90Vr"]},{"@type":"Person","@id":"https:\/\/www.vcro.com.tw\/#\/schema\/person\/2f08cc59b04b0a3bd4c58d32eb630c43","name":"VCRO","sameAs":["https:\/\/www.vcro.com.tw"],"url":"https:\/\/www.vcro.com.tw\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/82","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=82"}],"version-history":[{"count":9,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/82\/revisions"}],"predecessor-version":[{"id":1546,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/82\/revisions\/1546"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=\/wp\/v2\/media\/1727"}],"wp:attachment":[{"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=82"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=82"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vcro.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=82"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}